[Photodynamic therapy with hematoporphyrin derivatives in cervico-facial basaliomas and epidermoid carcinoma in stage I and II].
Cancer of the cervico-facial region often requires destructive procedures followed by complicated reconstructive surgical techniques. We have studied 77 patients with T1 and T2 head and neck cancers, who get photodynamic therapy using hematoporphyrin derivates. Biopsies taken two months after therapy revealed histologic complete responses in 95% of the cases. Additionally the cosmetic results of the photodynamic therapy were superior to conventional surgery.
Feyh
J
J
Cátedra de Otorrinolaringología, Ludwig-Maximilians-Universidad de Munich.
Bujía
J
J
Kastenbauer
E
E
D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000473:pathology; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006414:Hematoporphyrin Photoradiation; D006801:Humans; D009367:Neoplasm Staging; D011446:Prospective Studies
Terapia fotodinámica con derivados hematoporfirínicos en los estadios I y II de basaliomas y carcinomas epidermoides de localización cervicofacial.